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Abstract
Background:  We previously described the construction of an HIV-1 envelope glycoprotein
complex (Env) that is stabilized by an engineered intermolecular disulfide bond (SOS) between
gp120 and gp41. The modified Env protein antigenically mimics the functional wild-type Env
complex. Here, we explore the effects of the covalent gp120 – gp41 interaction on virus replication
and evolution.
Results: An HIV-1 molecular clone containing the SOS Env gene was only minimally replication
competent, suggesting that the engineered disulfide bond substantially impaired Env function.
However, virus evolution occurred in cell culture infections, and it eventually always led to
elimination of the intermolecular disulfide bond. In the course of these evolution studies, we
identified additional and unusual second-site reversions within gp41.
Conclusions:  These evolution paths highlight residues that play an important role in the
interaction between gp120 and gp41. Furthermore, our results suggest that a covalent gp120 –
gp41 interaction is incompatible with HIV-1 Env function, probably because this impedes
conformational changes that are necessary for fusion to occur, which may involve the complete
dissociation of gp120 from gp41.
Background
The trimeric HIV-1 envelope glycoprotein complex (Env)
mediates viral entry into susceptible target cells. The sur-
face subunit (SU; gp120) attaches to the receptor (CD4)
and the coreceptor (CCR5 or CXCR4) on the cell surface,
and subsequent conformational changes within the Env
complex lead to membrane fusion mediated by the trans-
membrane subunit (TM; gp41) [1-4]. After intracellular
cleavage of the precursor gp160 protein, three gp120 sub-
units stay non-covalently associated with three gp41 sub-
units. However, these non-covalent interactions are weak
and gp120 dissociates easily from gp41, a process that, if
it occurs spontaneously and prematurely, inactivates the
Env complex and leads to the exposure of non-neutraliz-
ing, immune-decoy epitopes on both gp120 and gp41 [5-
7]. HIV-1 vaccine strategies aimed at generating neutraliz-
ing antibodies have yielded various Env immunogens that
have gp120 stably attached to gp41, usually by
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elimination of the natural cleavage site between gp120
and gp41. Uncleaved Env proteins, however, like the dis-
sociated subunits, expose non-neutralizing epitopes [5-9].
We previously described the construction of a soluble Env
variant that is stabilized by the introduction of an inter-
molecular disulfide bond between gp120 and the gp41
ectodomain (gp41e) [9,10]. This SOS gp140 protein is
cleaved and it is antigenically similar to native Env. Thus,
neutralizing epitopes are exposed while several non-neu-
tralizing epitopes, which are also not accessible on the
functional Env complex, are occluded. The SOS gp140
protein is conformationally flexible in that CD4 can
induce conformational changes that expose the corecep-
tor binding site. Moreover, SOS Env can be rendered fully
functional by reduction of the intermolecular disulfide
bond upon the engagement of CD4 and a coreceptor
[11,12]. Extensive mutagenesis revealed that the appropri-
ate positioning of the intermolecular disulfide bond is
essential. Thus, only the introduction of cysteines at posi-
tion 501 in gp120 and 605 in gp41 yielded a stable, prop-
erly folded gp120/gp41 complex [9]. The extra disulfide is
indeed formed, and there is no evidence that the native
intramolecular disulfide bonds are affected.
Stabilization of the native Env complex by disulfide bond
linkage is likely to impose constraints on Env function
because a certain degree of flexibility is probably essential
for Env to undergo the conformational changes that even-
tually lead to fusion of the viral and cellular membranes.
The gp120 – gp41 interface is considered to be structurally
flexible, so constraining its motion might have adverse
effects [13]. For example, the conformational changes in
gp120 that are induced by receptor and coreceptor bind-
ing might not be transduced to the gp41 fusion machinery
because of the engineered disulfide bond between the two
subunits. In addition, appropriately timed gp120 shed-
ding may be necessary for receptor-mediated fusion, and
this step is blocked by the SOS disulfide bond bridge. We
have investigated whether HIV-1 would be able to accept
the engineered disulfide bond by spontaneous adaptation
and optimization during evolution in cell culture. This
exercise could learn us more about the interaction
between gp120 and gp41. Identifying compensatory
mutations that would accommodate the SOS disulfide
bond in a replicating virus might also be useful for the
design of improved Env immunogens.
Results and Discussion
Replication of HIV-1 mutants with cysteine substitutions in 
gp120 and gp41
We investigated the replication potential of HIV-1 con-
taining cysteine substitutions that are able to form an
intersubunit disulfide bond between gp120 and gp41.
The A501C and T605C substitutions alone or in combina-
tion (SOS Env) were introduced into the molecular clone
of the CXCR4-using strain HIV-1LAI (fig. 1A). Virus stocks
were generated in non-susceptible C33A producer cells by
transient transfection. The three mutant viruses and the
wild-type (wt) parent all produced comparable amounts
of CA-p24 antigen (fig. 1B). The virus stocks were then
used to infect MT-2 T cells (fig. 1C). The SOS virus was not
able to initiate a spreading infection and the A501C single
mutant was also replication-defective. In contrast and per-
haps surprisingly, the T605C single mutant replicated effi-
ciently, albeit with delayed kinetics compared to the wt
control. Similar results were obtained using the SupT1 T
cell line (results not shown). When we studied virus entry
into a reporter cell line, we measured efficient entry of the
wt and T605C viruses, while the A501C and SOS viruses
were not able to enter the target cells (fig. 1D). We con-
clude that the SOS Env protein does not support virus rep-
lication, consistent with previous studies using a cell-cell
fusion assay or Env-pseudotyped viruses in a single-cycle
infection protocol [11,12].
Evolution of HIV-1 with a disulfide bond between gp120 
and gp41
To investigate the structural constraints imposed upon the
SOS Env protein by the engineered disulfide bond and to
identify viruses with potentially interesting second-site
reversions, we passaged several virus cultures for a pro-
longed period (table 1, cultures A-C). One culture con-
taining the A501C virus was also maintained for many
weeks (table 1, culture D). Despite these efforts, we were
unable to obtain any revertants of the two replication-
impaired mutant viruses, underlining the deleterious
effect of the intermolecular disulfide bond and the A501C
single substitution on Env function. We therefore revised
our experimental design by varying the cell type and
increasing the amount of the transfected plasmid DNA.
We also added low concentrations of β-mercaptoethanol
(BME) to some of the cultures, reasoning that this reduc-
ing agent may reduce the SOS disulfide bond, thereby
increasing the fusion capacity of SOS Env and virus evolu-
tion [11,12]. We first determined the concentrations of
BME that are toxic for MT-2 and SupT1 cells. At 0.3 mM,
BME marginally impaired the growth of both cell types, so
we did not exceed this concentration. The various cultures
are listed in table 1. The evolution experiments were
started by transfecting 5 × 106 cells with 10 or 40 µg of the
SOS Env molecular clone. The cells were cultured in small
(T25) flasks for 7 days and subsequently transferred to
large (T75) flasks to increase the probability of detecting a
rare evolution event.
The SOS Env virus acquires compensatory second-site 
reversions
After 7 weeks of culture, we detected virus spread, as meas-
ured by CA-p24 production, in one of the 15 culturesRetrovirology 2004, 1 http://www.retrovirology.com/content/1/1/3
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(culture X in table 1). This culture contained MT-2 cells
grown with 0.3 mM BME. To investigate whether replica-
tion of the evolved virus was triggered by or even depend-
ent on the reducing agent, we passaged the variant onto
fresh MT-2 cells in the absence or presence of BME (fig. 2).
The evolved virus replicated poorly, but spread more effi-
ciently without BME. This suggests that BME was not
required for Env function and the toxicity of this com-
pound may actually have hindered virus replication. Nev-
ertheless, it remains possible that the initial evolution
event itself was facilitated by BME, for instance by trigger-
ing entry of the original input SOS virus into cells.
Proviral DNA was isolated from the positive culture X
after 7 weeks and the env  gene was PCR-amplified.
Sequencing of the viral quasispecies revealed that the orig-
inal SOS cysteine substitutions were still present. Two
additional reversions were found: L593Q in the gp41 loop
12 residues upstream of the introduced A605C SOS
cysteine, and T719I in the gp41 intracytoplasmic tail (fig.
3A).
Prolonged evolution leads to elimination of the SOS 
disulfide bond
The slowly replicating virus present in culture X (SOS-X)
was used to initiate two new infections that were contin-
ued for another two months to monitor additional evolu-
tion events (cultures X3 and X4). Consistent with a further
improvement of their fitness, the resulting viruses repli-
cated faster than the original SOS-X virus, as monitored by
HIV-1LAI with an SOS-linked Env is replication-defective Figure 1
HIV-1LAI with an SOS-linked Env is replication-defective. A. Schematic representation of the A501C and T605C single and dou-
ble (SOS) mutants used in this study. Free cysteines with a sulfhydryl group are indicated by SH and an intermolecular disulfide 
bond between gp120 and gp41 is indicated by SS. B. 375 × 103 MT-2 T cells were infected with 1.5 ng CA-p24 of C33A-pro-
duced virus and virus spread was monitored for 7 days by CA-p24 ELISA.
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the rate of appearance of syncytia and CA-p24 antigen
production. The env genes were PCR-amplified from pro-
viral DNA and sequenced (fig. 3A). In both cultures, the
SOS cysteine at position 605 had been replaced by a tyro-
sine, thus eliminating the intersubunit disulfide bond.
Note that the wt amino-acid at position 605 is a threo-
nine, but reversion to the wt codon is unlikely because it
requires two nucleotide changes; a change to tyrosine
requires only a single G-to-A transition. An additional
reversion event was observed in each culture: Q591L in
culture X3 and K487N in culture X4 (fig. 3A).
In an attempt to study the properties of a replication-com-
petent, clonal virus that maintained the SOS disulfide
bond, we cloned the env gene from the original escape
virus in culture X and inserted it into the HIV-1LAI molec-
ular clone. The variant molecular clone contained the
L593Q and T719I changes, but retained the SOS disulfide
bond and is designated SOS-X (A501C T605C L593Q
T719I). We used this molecular clone to initiate multiple
new and independent evolution experiments, hoping that
escape routes might be identified that would not result in
elimination of the intersubunit disulfide bond. MT2 cells
were transfected with 40 µg of pLAI-SOS-X and cultured
for 6–10 weeks in the absence of BME. We eventually
observed faster replicating viruses in most cultures, as
indicated by the appearance of syncytia and the produc-
tion of CA-p24. The proviral env genes were PCR-ampli-
fied and sequenced (fig. 3B). Strikingly, the viruses in all
9 independent cultures eliminated the intersubunit
disulfide bond via the C605Y first-site pseudo-reversion
that we previously observed in the X3 and X4 cultures. In
three cultures, no mutations other than this C605Y
change occurred. Surprisingly, the L593Q substitution,
which was selected in the initial SOS-X evolution, was
eventually lost in 6 cultures by a de novo first-site reversion
(Q593L). Two cultures exemplified that the Q593L rever-
sion occurred after the loss of the cysteine at position 605
(cultures L and Q, compare sequences from weeks 6 and
10). The idea that the C605Y change has to precede
Table 1: SOS evolution cultures
culture mutant cell line pLAI (µg) BME (mM) Reversiona
AS O S S u p T 1 1 0 - -
BS O S S u p T 1 1 0 - -
CS O S S u p T 1 1 0 - -
D A501C SupT1 10 - -
ES O S S u p T 1 1 0 --
F1 SOS SupT1 10 0.1 -
F3 SOS SupT1 10 0.3 -
IS O S S u p T 1 4 0 --
J1 SOS SupT1 40 0.1 -
J3 SOS SupT1 40 0.3 -
QS O S M T - 2 1 0- -
RS O S M T - 2 1 0 0 . 1 -
TS O S M T - 2 1 0 0 . 3 -
US O S M T - 2 4 0 - -
VS O S M T - 2 4 0 0 . 1 -
XS O S M T - 2 4 0 0 . 3 +
a after 7 weeks (12 weeks for cultures A-D)
Replication of the evolved SOS revertant virus in the absence  and presence of reducing agent Figure 2
Replication of the evolved SOS revertant virus in the absence 
and presence of reducing agent. 100 µl (78 ng CA-p24) of the 
cell-free culture supernatant of culture X (see the text) was 
passaged onto 5 × 106 fresh MT-2 T cells in the presence or 
absence of 0.3 mM BME and virus spread was measured for 
10 days.
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Schematic of SOS virus evolution Figure 3
Schematic of SOS virus evolution. A. The wt Env protein and the SOS mutant are shown. SOS Env formed the starting point 
for evolution of the revertant virus in culture X at week 7, and this culture was split in two and cultured up to week 15 (X3 
and X4; see the text). B. Virus evolution starting with the SOS-X molecular clone (A501C T605C L593Q T719I). Nine inde-
pendent cultures were followed over time.
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Q593L reversion is supported by the fact that three cul-
tures contain exclusively the C605Y reversion, but no cul-
tures have Q593L as an individual substitution. In one
culture, we detected a very similar amino-acid substitu-
tion nearby: Q591L (culture Q at week 6), which was
already observed in culture X3. The Q culture evolved fur-
ther in a surprising way: both the 593 and 591 residues
eventually reverted to the wt residues (culture Q at week
10).
Oscillation and co-variation of the L593Q and Q591L 
substitutions in gp41
The various virus evolution pathways are depicted in fig-
ure 4. This scheme combines the results of the original
cultures (X3 and X4) and the subsequent experiments (K
through T), yielding 11 evolution events that started with
SOS-X (A501C T605C L593Q T719I). The T719I substitu-
tion in the gp41 intracytoplasmic domain (in culture X)
and the K487N substitution (in culture X4) were not
tested further and are omitted from the scheme. It is pos-
sible that these reversions contributed to the gain of repli-
cation capacity by the SOS-X and X4 variants, respectively,
but we chose to focus on residues in the gp41 ectodomain
(residues 591 and 593). These residues are located near
SOS evolution pathways Figure 4
SOS evolution pathways. The SOS-escape routes are summarized by focusing on four key amino-acid positions. The two SOS 
cysteines are marked in yellow, and loss of a cysteine changes the colour to grey. The oscillating 591 and 593 residues are also 
color-coded: red is L and, blue is Q. The observed frequencies of various reversions are indicated above the arrows. Both the 
original cultures (X3 and X4 in fig. 3A) and the subsequent cultures (K through T in fig. 3B) are included. The K487N reversion 
is left out of the scheme since it was only observed once (in X4) and the T719I reversion is not indicated since it was 
unchanged after its appearance in culture X.
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Replication of the L593Q and Q591L mutant viruses. 5 × 106 
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the SOS 605 cysteine in a region that is important for
interaction with gp120 [9,13-17].
The selection of the L593Q substitution in the SOS to
SOS-X evolution strongly suggests that it is advantageous
for viral replication in the presence of the SOS disulfide
bond. However, it appears to be disadvantageous and is
eliminated once the disulfide bond is lost by the C605Y
substitution. Alternatively, the negative effect of the
L593Q substitution in the absence of the disulfide bond
can be partially overcome by acquisition of the compen-
satory Q591L substitution, as exemplified by two virus
cultures that follow this pathway (fig. 3: X3 and Q, and fig.
4). However, given sufficient evolution time in the
absence of the SOS disulfide bond, both 591 and 593 res-
idues revert back to the wt sequence (fig. 3: culture Q).
To analyze the effects of the L593Q and Q591L changes,
we constructed molecular clones containing these substi-
tutions, either individually or in combination, in the con-
text of SOS (A501C T605C) and the revertant virus
(A501C C605Y). However, the poor replication capacity
of these viruses did not allow any significant further test-
ing (results not shown). We therefore studied the effect of
the L593Q and Q591L substitutions in the context of the
wt virus. MT-2 T cells were transfected with the appropri-
ate molecular clones and virus spread was measured (fig.
5). The L593Q mutant replicated with a delay of approxi-
mately 4 days compared to the wt virus. Replication of the
Q591L mutant was significantly better, with a delay of
only one day compared to the wt virus. Of note is that the
double mutant L593Q Q591L had an intermediate phe-
notype, the delay being 3 days. Similar results were
obtained in independent infection experiments (not
shown). Thus, whereas the Q591L substitution is slightly
disadvantageous for the wt Env protein, it can partially
compensate for the defect caused by the L593Q substitu-
tion. The T719I substitution that was also found in the
revertant SOS-X virus did not have any effect on replica-
tion of the wt virus (results not shown).
Modeling of reversions in the gp41 structure model
To better understand the molecular mechanisms of the
oscillating 591 and 593 substitutions, we analyzed the
substitutions at positions 591, 593 and 605 in a structure
model of the HIV-1 gp41 loop region (fig. 6). The model
is based on the SIV gp41 NMR structure and represents the
post-fusion, six-helix bundle state of gp41 [18,19]. It was
used because the available crystal structures of the six-
helix bundle do not include the loop region [20-22].
Ideally, we would also like to model the substitutions in
the pre-fusion structure of gp41 since they are likely to
exert their effect on the Env complex at this stage. How-
ever, the structure of gp41 in the pre-fusion state is cur-
rently unknown. As reported previously, residue 605
(yellow in fig. 6) is on the outside of the gp41 molecule
and thus available for an interaction with gp120 [18]. The
side chain of residue 605 points outwards such that sub-
stitutions here would not be expected to disrupt the loop
structure. Indeed, the cysteine-to-tyrosine reversion that
we observed can easily be accommodated at position 605.
Residues 591 and 593 are located at an equivalent posi-
tion in the interior of the gp41 core, but the orientation of
their side chains differs (fig. 6). The side chain of residue
593 (cyan in fig. 6) points towards the interior of the loop,
thereby establishing an interaction with its counterparts
in the other subunits at the trimer axis. This 593 Leu-Leu-
Leu triplet stabilizes the loop structure by hydrophobic
interactions. Similar hydrophobic Leu-Leu-Leu and Ile-
Ile-Ile interactions stabilize the upstream coiled coil
region (e.g. residues L545, I548, L555, I559, L566, I573,
L576, L587). It is evident that L593 does not directly
interact with residues 591 or 605. Leucine 593 can be
replaced by glutamine without disrupting the backbone.
This change might weaken the loop structure due to the
introduction of hydrophilic side chains into the protein
interior, but the glutamine side chains may rearrange to
form hydrogen bonds to regain some of the lost energy.
Similar to Gln-Gln-Gln interactions that are present in the
coiled coil domain (e.g. residues Q552, Q562).
The side chain of residue 591 (purple in fig. 6) is located
at the end of the N-terminal helix. It is partially occluded
in the interior of gp41 and partially exposed on the sur-
face. It does not directly interact with either residue 593 or
605. Replacing glutamine 591 with leucine is possible
without perturbing the backbone (fig. 6C and 6D). In
conclusion, the Q591L and L593Q substitutions do not
appear to have dramatic effects on the gp41 post-fusion
conformation, which is consistent with the notion that
these reversions may exert their effects on the gp41 –
gp120 interaction in the pre-fusion form of the Env
complex.
Conclusions
The initial goal of our forced evolution studies was to gen-
erate SOS Env variants that could replicate despite having
an intermolecular disulfide bond between gp120 and
gp41. The presence of a disulfide bond between the SU
and TM subunits of other viruses, including retroviruses,
provides a rationale for this study [23-40]. The evolution-
ary selection of a disulfide bond-stabilized, but functional
HIV-1 Env complex would have been useful for mechanis-
tic studies and the design of variant SOS Env immuno-
gens. A functional, covalently-linked Env complex would
imply that gp120 shedding is not necessary for Env-medi-
ated fusion to occur. This is still a matter of debate, but
our results strongly suggest that gp120 dissociation from
gp41 is required for fusion activity. A functional, cova-Retrovirology 2004, 1 http://www.retrovirology.com/content/1/1/3
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lently-linked Env complex would also be an interesting
immunogen, since a functional Env complex should be a
faithful mimic of the functional virion-associated Env
complex. Note, however, that during the course of our
evolution experiments, it became clear that unmodified
SOS Env is in fact functional upon reduction of the
disulfide bond, implying that it does truly mimic the func-
tional Env complex on virions [11,12].
We did identify one SOS variant that replicated extremely
poorly, but still retained the engineered cysteines (SOS-X,
containing the L593Q reversion). This poorly replicating
variant seemed a good candidate for subsequent evolu-
tion experiments. However, the cysteine at position 605
was always lost over time in multiple independent cul-
tures. The L593Q reversion substitution may in fact
destabilize the SOS disulfide bond (see below), thus bias-
ing the subsequent evolution towards elimination of the
disulfide bond. In conclusion, we were not able to obtain
efficiently replicating viruses that retained the SOS
disulfide bond. A rigid, covalent interaction between
gp120 and gp41 is probably deleterious for HIV-1 replica-
tion. The dissociation of gp120 from gp41, or a significant
shift in the geometry of the two subunits, may be essential
for fusion to occur. This conclusion is supported by the
observation that SOS Env will undergo fusion efficiently
once a reducing agent is added to break the engineered
disulfide bond subsequent to receptor engagement
[11,12].
Modeling of the SOS reversions in structure model of the HIV-1 gp41 ectodomain [18] Figure 6
Modeling of the SOS reversions in structure model of the HIV-1 gp41 ectodomain [18]. The Cα atoms of the relevant residues 
are indicated as spheres in fig. A and B, using the following color scheme: C605 is yellow, L593 is cyan, and Q591 is purple. 
The side chains in fig. C and D, use the same color scheme. Panels A and C depict a side view of the gp41 loop region, panels 
B and D a top view from the perspective of the target membrane (and of gp120).
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An intriguing question is why the loss of the SOS disulfide
bond occurred in multiple independent cultures via a sub-
stitution of C605, but never of C501. This is a surprising
finding given the fact that a virus with a single cysteine at
position 605 is replication competent, whereas a virus
with a single cysteine at position 501 is not (fig. 1). It is
possible that the evolutionary possibilities at position 501
are more restricted. For example, it may take more than
one nucleotide change in codon 501 to acquire a func-
tional amino-acid. The wt A501 is strongly conserved in
natural isolates and it would require at least 2 nucleotide
changes to remake the C501 codon into a triplet that is
present in natural virus isolates. The underlying Rev
responsive element may impose additional constraints on
the evolution of this codon. In contrast, the C605Y rever-
sion is generated by a relatively easy G-to-A transition
[41], and tyrosine is tolerated at this position, as exempli-
fied by the presence of a tyrosine in subtype O isolates
http://www.hiv.lanl.gov/content/index.
The evolutionary oscillation of the 591 and 593 residues
(Q591 L593 or L591 Q593) has implications for under-
standing the molecular basis of the gp120-gp41 interac-
tion. Molecular modeling indicated that these reversions
do not have a drastic effect on the loop structure in the
post-fusion, six-helix bundle configuration of gp41,
although the initial L593Q substitution probably has a
destabilizing effect. In the context of the SOS disulfide
bond, destabilization of the loop region of gp41 could
allow the disulfide bond-linked gp120 subunit to be more
easily accommodated. However, inspection of the post-
fusion gp41 structure does not readily explain why the
Q591L secondary reversion compensates for the L593Q
change in the absence of the SOS disulfide bond. We
therefore favor an alternative explanation in which the
initial L593Q change destabilizes the gp120-gp41 interac-
tion. Of note is that the crystal structure of the SIV ectodo-
main places the side chain of residue 593 on the outside
of the molecule in contrast to the NMR structure [42]. A
destabilizing effect of L593Q would be consistent with
previous mutagenesis studies [13,16]. For example, the
L593A substitution virtually abolishes gp120-gp41 associ-
ation [16]. The conservative L593V substitution also
affects the gp120-gp41 interaction although the effect is
more subtle [13]. Interestingly, the importance of residues
involved in the gp120-gp41 interaction, including residue
593, can be dependent on the context of the particular
Env, e.g. its coreceptor usage, and differs among viral iso-
lates [13].
The L593Q reversion could either destabilize the SOS
disulfide bond or prevent its formation. We were unable
to detect such an effect in biochemical assays using solu-
ble SOS gp140 (results not shown), but the effect may be
marginal, since the positive effect on SOS virus replication
is also minor. Substitutions at position 591 (Q591A and
Q591K) are much better tolerated with regard to Env
function [16], which may explain why the Q591L rever-
sion could act as an intermediate in two independent evo-
lution cultures. In another study on the idiotypic mimicry
of two monoclonal antibodies, the stretch of residues
591–594 was shown to be an interaction site for gp120
[43]. Thus, previous mutagenesis studies, idiotypic mim-
icry and the forced evolution studies presented here all
point to an important role for this gp41 domain in the
interaction with gp120.
The stability of the gp120-gp41 interaction is delicately
balanced. Too weak an interaction is deleterious to virus
replication because it results in premature gp120
shedding, loss of Env function and loss of virus replica-
tion. However, a too rigid, and certainly a covalent inter-
action is also incompatible with HIV-1 Env function,
probably because this impedes conformational changes
that are necessary for fusion to occur, which may even
include the complete dissociation of gp120 from gp41
[44,45].
Methods
Plasmid Constructs
The plasmid pRS1, generated to subclone mutant env
genes, was generated as follows. First, the SalI-BamHI
fragment from a molecular clone of HIV-1LAI (pLAI) [46]
was cloned into pUC18 (Roche, Indianapolis, IN). A PstI-
StuI fragment from the resulting plasmid was then cloned
into a pBS-SK(+)-gp160 plasmid with the SalI-XhoI
sequences of pLAI. Mutations were introduced in pRS1
using the Quickchange mutagenesis kit (Stratagene, La
Jolla, CA) and verified by DNA sequencing. Mutant env
genes in pRS1 were cloned into pLAI as SalI-BamHI frag-
ments. The numbering of individual amino-acids is based
on the HIV-1HXB2 gp160 sequence.
Cells and transfection
SupT1 T cells and C33A cervix carcinoma cells were main-
tained in RPMI 1640 medium and Dulbecco's modified
eagle'S medium (DMEM), respectively (Life Technologies
Ltd., Paisley, UK), supplemented with 10% fetal calf
serum (FCS), penicillin (100 U/ml) and streptomycin
(100  µg/ml) as previously described [47]. SupT1 and
C33A cells were transfected with pLAI constructs by elec-
troporation and Ca2(PO4)3 precipitation, respectively, as
described elsewhere [48].
Virus entry and infection
Virus stocks were produced by transfecting C33A cells
with the appropriate pLAI constructs. The virus containing
supernatant was harvested 3 days post-transfection, fil-
tered and stored at -80°C. The virus concentration was
quantified by capsid CA-p24 ELISA as described previ-Retrovirology 2004, 1 http://www.retrovirology.com/content/1/1/3
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ously [49]. The resulting values were used to normalize
the amount of virus in subsequent infection experiments,
which were performed as follows. T cells (3.75 × 105) were
infected with 1.5 ng CA-p24 of HIV-1LAI (produced in
C33A cells) per well of a 24-well plate. Subsequent virus
spread was monitored by CA-p24 ELISA for 14 days.
LuSIV cells, stably transfected with an LTR-luciferase con-
struct [50], were infected with 200 ng CA-p24/300 × 103
cells/ml in a 48 well plate. Cells were maintained in the
presence of 200 nM saquinavir to prevent additional
rounds of virus replication. Luciferase activity was meas-
ured after 48 hrs.
Virus evolution
For evolution experiments, 5 × 106 SupT1 cells were trans-
fected with 40 µg pLAI by electroporation. The cultures
were inspected regularly for the emergence of revertant
viruses, using CA-p24 ELISA and/or the appearance of
syncytia as indicators of virus replication. At regular inter-
vals, cells and filtered supernatant were stored at -80°C
and virus was quantitated by CA-p24 ELISA. When a rever-
tant virus was identified, DNA was extracted from infected
cells [51], then proviral env sequences were PCR-ampli-
fied and sequenced. The complete env genes of the provi-
ral DNA of cultures X, X3 and X4 were sequenced. Only
the C5 region and gp41 were sequenced in subsequent
evolution experiments.
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